Localization of β2-glycoprotein 1 in late endosomes of human endothelial cells

Thrombosis and Haemostasis

Volumn 85, Issue 5, 2001, Pages 903-907

  Dunoyer Geindre, S ^a   Kruithof, E K O ^a   Galve De Rochemonteix, B ^a   Rosnoblet, C ^a   Gruenberg, J ^a   Reber, G ^a   De Moerloose, P ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Anti phospholipid antibodies; Endothelial cells; Late endosomes; 2 glycoprotein 1

Indexed keywords

BETA2 GLYCOPROTEIN 1; MANNOSE RECEPTOR; MONOCLONAL ANTIBODY; PHOSPHOLIPID ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN ANTIBODY; ANTIBODY; ANTICOAGULANT AGENT; GLYCOPROTEIN; SOMATOMEDIN B RECEPTOR;

ARTICLE; CELL SURFACE; CELLULAR DISTRIBUTION; DISEASE ASSOCIATION; ENDOSOME; ENDOTHELIUM CELL; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RECURRENT ABORTION; THROMBOPHILIA; UMBILICAL VEIN; ANTIPHOSPHOLIPID SYNDROME; CHEMISTRY; CYTOLOGY; DRUG EFFECT; FLUORESCENCE MICROSCOPY; IMMUNOLOGY; METABOLISM; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM;

ANTIBODIES; ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; ENDOSOMES; ENDOTHELIUM, VASCULAR; GLYCOPROTEINS; HUMANS; MICROSCOPY, FLUORESCENCE; RECEPTOR, IGF TYPE 2; UMBILICAL VEINS;

EID: 0034744188     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615766     Document Type: Article

References (26)

1. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome
2. Immunology of the antiphospholipid antibody syndrome
3. 2 glycoprotein 1 antibodies: Detection and association with thrombosis
4. 2-glycoprotein-I binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome
5. 2GP1 but no antibodies detectable in standard antiphospholipid assays
6. 2GP1 antibodies in a large series of European patients with systemic lupus erythematosus
7. Testing for the antiphospholipid syndrome: Importance of IgA and anti-beta 2-glycoprotein 1
8. Immunization with anticardiolipin cofactor (beta-2 glycoprotein-1) induces antiphospholipid syndrome in naive mice
9. Thrombogenic properties of anti-cardiolipin antibodies induced by beta 2 glycoprotein 1 and human immunoglobulins G antiphospholipid antibodies
10. Induction of experimental antiphospholipid syndrome in PL/J mice following immunization with beta2 glycoprotein 1
11. 2-Glycoprotein I as "cofactor" for antiphospholipid reactivity with endothelial cells
12. 2-GPI) mRNA is expressed by several cell types involved in anti-phospholipid syndrome-related tissue damage
13. Interaction of anti-phospholipid antibodies with late endosomes of human endothelial cells
14. 2-Glycoprotein 1
15. A lipid associated with the antiphospholipid syndrome regulates endosome structure and function
16. 2Glycoprotein I and induce endothelial activation
17. High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II
18. Differential sorting of lysosomal enzymes in mannose 6-phosphate receptor-deficient fibroblasts
19. The two mannose 6-phosphate receptors transport distinct complements of lysosomal proteins
20. Alternative mechanisms for trafficking of lysosomal enzymes in mannose 6-phosphate receptor-deficient mice are cell type-specific
21. Polymorphonuclear leukocyte lysosomal proteases, cathepsins B and D affect the fibrinolytic system in human umbilical vein endothelial cells
22. Neutrophil derived cathepsin G induces potentially thrombogenic changes in human endothelial cells: A scanning electron microscopy study in static and dynamic conditions
23. Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II
24. Annexin II is a major component of fusogenic endosomal vesicles
25. Separation of early steps in endocytic membrane transport
26. 2-Glycoprotein-1 mRNA transcripts are expressed by hepatocytes but not by resting or activated human endothelial cells